Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 19 | 2024 | 902 | 3.130 |
Why?
|
| Peritoneal Dialysis | 9 | 2024 | 127 | 2.400 |
Why?
|
| Renal Dialysis | 14 | 2024 | 902 | 1.440 |
Why?
|
| Catheters, Indwelling | 4 | 2024 | 149 | 1.210 |
Why?
|
| Catheter-Related Infections | 6 | 2024 | 134 | 0.990 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 746 | 0.970 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 2 | 2020 | 22 | 0.790 |
Why?
|
| Hydrothorax | 1 | 2020 | 11 | 0.660 |
Why?
|
| Calcimimetic Agents | 1 | 2019 | 5 | 0.640 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 16 | 0.630 |
Why?
|
| Kidney Transplantation | 4 | 2023 | 556 | 0.490 |
Why?
|
| Renal Insufficiency | 4 | 2024 | 229 | 0.460 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2019 | 49 | 0.440 |
Why?
|
| Latent Tuberculosis | 1 | 2014 | 75 | 0.410 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2014 | 87 | 0.410 |
Why?
|
| Child | 26 | 2024 | 25112 | 0.410 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2022 | 86 | 0.340 |
Why?
|
| Catheterization | 3 | 2022 | 232 | 0.310 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2023 | 82 | 0.310 |
Why?
|
| Renal Replacement Therapy | 3 | 2023 | 147 | 0.300 |
Why?
|
| Nephrosis, Lipoid | 1 | 2009 | 11 | 0.300 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 49 | 0.290 |
Why?
|
| Cost Savings | 1 | 2008 | 76 | 0.290 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 209 | 0.280 |
Why?
|
| Oxygen | 2 | 2021 | 544 | 0.270 |
Why?
|
| Infant | 11 | 2024 | 12803 | 0.270 |
Why?
|
| Ascitic Fluid | 2 | 2017 | 29 | 0.260 |
Why?
|
| Humans | 35 | 2024 | 126134 | 0.250 |
Why?
|
| Child, Preschool | 12 | 2024 | 14375 | 0.250 |
Why?
|
| Hypertension | 2 | 2019 | 1281 | 0.250 |
Why?
|
| Adolescent | 17 | 2024 | 19986 | 0.250 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 601 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2008 | 378 | 0.230 |
Why?
|
| Retrospective Studies | 12 | 2023 | 16831 | 0.220 |
Why?
|
| Peritonitis | 2 | 2024 | 74 | 0.220 |
Why?
|
| Nephrology | 2 | 2016 | 149 | 0.210 |
Why?
|
| Observer Variation | 1 | 2024 | 306 | 0.200 |
Why?
|
| Pruritus | 1 | 2023 | 47 | 0.200 |
Why?
|
| Kidney | 3 | 2023 | 1262 | 0.200 |
Why?
|
| Male | 21 | 2024 | 62225 | 0.200 |
Why?
|
| Oximetry | 2 | 2021 | 174 | 0.190 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2022 | 33 | 0.180 |
Why?
|
| Ureteral Obstruction | 1 | 2023 | 102 | 0.180 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 53 | 0.180 |
Why?
|
| Ureter | 1 | 2023 | 95 | 0.180 |
Why?
|
| Brain Chemistry | 1 | 2021 | 111 | 0.180 |
Why?
|
| Standard of Care | 2 | 2019 | 133 | 0.170 |
Why?
|
| Hematocrit | 1 | 2020 | 107 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 259 | 0.160 |
Why?
|
| Blood | 1 | 2020 | 100 | 0.160 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2020 | 55 | 0.160 |
Why?
|
| Female | 16 | 2024 | 68037 | 0.160 |
Why?
|
| Veins | 1 | 2020 | 99 | 0.160 |
Why?
|
| Infant Formula | 1 | 2020 | 104 | 0.150 |
Why?
|
| Venous Thrombosis | 2 | 2019 | 167 | 0.150 |
Why?
|
| Guideline Adherence | 2 | 2019 | 365 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 98 | 0.150 |
Why?
|
| Creatinine | 1 | 2020 | 360 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 108 | 0.140 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8381 | 0.140 |
Why?
|
| Bacteremia | 1 | 2022 | 419 | 0.140 |
Why?
|
| Pediatrics | 3 | 2019 | 1205 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 351 | 0.140 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 124 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 309 | 0.140 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 57 | 0.140 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 138 | 0.140 |
Why?
|
| Arterial Pressure | 1 | 2019 | 123 | 0.140 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 77 | 0.140 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 9 | 0.140 |
Why?
|
| Sevelamer | 1 | 2017 | 11 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 504 | 0.140 |
Why?
|
| Hyperphosphatemia | 1 | 2017 | 19 | 0.140 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 16 | 0.130 |
Why?
|
| Chelating Agents | 1 | 2017 | 50 | 0.130 |
Why?
|
| Chylous Ascites | 1 | 2017 | 10 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 308 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 494 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2021 | 343 | 0.130 |
Why?
|
| Heart | 1 | 2021 | 645 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12393 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 143 | 0.120 |
Why?
|
| Peritoneum | 1 | 2016 | 38 | 0.120 |
Why?
|
| Texas | 3 | 2017 | 3536 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 223 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 125 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2019 | 673 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 10374 | 0.120 |
Why?
|
| Quality of Life | 2 | 2023 | 2014 | 0.120 |
Why?
|
| Sepsis | 1 | 2019 | 486 | 0.110 |
Why?
|
| Public Policy | 1 | 2015 | 54 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 160 | 0.110 |
Why?
|
| Skin Tests | 1 | 2014 | 79 | 0.110 |
Why?
|
| Young Adult | 5 | 2019 | 9635 | 0.100 |
Why?
|
| Hyperammonemia | 1 | 2013 | 60 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 689 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1005 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2014 | 469 | 0.080 |
Why?
|
| Incidence | 1 | 2018 | 3193 | 0.080 |
Why?
|
| Transplant Recipients | 2 | 2022 | 230 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 700 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2009 | 4894 | 0.080 |
Why?
|
| Glomerular Mesangium | 1 | 2009 | 19 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5107 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2009 | 127 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 413 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 301 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2008 | 106 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 418 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 2766 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 377 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2009 | 214 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 30314 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 425 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 527 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2926 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3260 | 0.060 |
Why?
|
| Biopsy | 1 | 2009 | 1221 | 0.060 |
Why?
|
| United States | 2 | 2018 | 11187 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 650 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 777 | 0.050 |
Why?
|
| Nitrogen | 1 | 2024 | 122 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 223 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3658 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2024 | 298 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 35 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 101 | 0.040 |
Why?
|
| Living Donors | 1 | 2022 | 115 | 0.040 |
Why?
|
| Blood Volume | 1 | 2021 | 70 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2024 | 6178 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 88 | 0.040 |
Why?
|
| Graft Survival | 1 | 2022 | 453 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2019 | 19 | 0.040 |
Why?
|
| Renal Veins | 1 | 2019 | 33 | 0.040 |
Why?
|
| Iliac Vein | 1 | 2019 | 28 | 0.040 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 50 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 490 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2019 | 66 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2019 | 47 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 48 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 159 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 183 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 449 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 324 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2022 | 555 | 0.040 |
Why?
|
| Arteries | 1 | 2019 | 196 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 218 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 430 | 0.030 |
Why?
|
| Iohexol | 1 | 2017 | 17 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2017 | 30 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2021 | 800 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Nephrology Nursing | 1 | 2016 | 2 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 54 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Myocardium | 1 | 2021 | 837 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 76 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 472 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 245 | 0.030 |
Why?
|
| Aorta | 1 | 2019 | 503 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 778 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 600 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2176 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1097 | 0.030 |
Why?
|
| Government | 1 | 2015 | 13 | 0.030 |
Why?
|
| Foundations | 1 | 2015 | 21 | 0.030 |
Why?
|
| Thrombosis | 1 | 2019 | 497 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 599 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 450 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 364 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 950 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 578 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 736 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1229 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1655 | 0.020 |
Why?
|
| Reoperation | 1 | 2016 | 791 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2016 | 547 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 765 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 969 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1823 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3149 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 661 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2016 | 516 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1220 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2752 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2981 | 0.010 |
Why?
|